drugset / Trial / NCT01320553

Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis

NCT01320553 ↗

Phase 2 Completed 122 enrolled Sun Pharma Advanced Research Company Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The present study will test if administration of different concentrations of 1334H eyedrops will be effective in treatment of allergic conjunctivitis in people with 10 yrs of age or older.

Timeline

Start
2011-06
Primary completion
2011-08
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject SPARC1102 Unknown 0.15 % Other
Subject SPARC1102 Unknown 0.3 % Other
Subject SPARC1102 Unknown 0.45 % Other

Indications